Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

NCT05878964 · clinicaltrials.gov ↗

RECRUITING

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Breast Cancer
Kidney Cancer
Bladder Cancer
Gastric Cancer
Skin Cancer
Melanoma
Head Neck Cancer

Interventions

OTHER: EQ-5D-5L questionnaire
OTHER: FACT-G (Functional Assessment of Cancer Therapy - General)
OTHER: FACT-EGFRI-18 (Functional Assessment of Cancer Therapy - Epidermal Growth Factor Inhibitors 18 Item)

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS